ABOUT US
CONTACT US
FAQ
PRIVACY POLICY
REFUND AND CANCELLATION
BLOGS
COMPANIES
REPORTS
0
U.S. (TOLL FREE)
+1 (315) 215-3225
Automative
0
U.S. (TOLL FREE)
+1 (315) 215-3225
Global Emphysema Treatment Medication Market Outlook, In‑Depth Analysis & Forecast to 2031
Published Date: November 2025
|
Report Code: QYRE-Auto-28B16808
Home | Market Reports | Health| Health Conditions| Heart & Hypertension
Global Emphysema Treatment Medication Market Research Report 2024
BUY CHAPTERS

Global Emphysema Treatment Medication Market Outlook, In‑Depth Analysis & Forecast to 2031

Code: QYRE-Auto-28B16808
Report
November 2025
Pages:150
QYResearch
Buy Now with 15% Discount
DESCRIPTION
TABLE OF CONTENT
TABLES & FIGURES
FEATURED COMPANIES
Emphasys Medical
Pfizer Inc
Uptake Medical
Inogen
Viatris
Boehringer Ingelheim International GmbH
Novartis
Astrazeneca plc
Orion Corporation
Teva Pharmaceutical Industries Ltd
Verona Pharma Plc
GlaxoSmithKline PLC
Pulmonx
Bioxyne
Intrexon
Icure Pharmaceuticals
Kamada

Emphysema Treatment Medication Market Size

The global Emphysema Treatment Medication market is projected to grow from US$ 4266 million in 2024 to US$ 5331 million by 2031, at a CAGR of 3.3% (2025-2031), driven by critical product segments and diverse end‑use applications.

Emphysema Treatment Medication Market

Emphysema Treatment Medication Market

Emphysema is a chronic and progressive lung condition characterized by damage to the air sacs in the lungs, known as alveoli. This damage leads to the deterioration of the lung tissue and results in decreased elasticity, making it difficult to breathe. The primary cause of emphysema is long-term exposure to irritants, most commonly cigarette smoke, although other factors such as air pollution and genetic predisposition can also contribute. Symptoms of emphysema include shortness of breath, chronic coughing, wheezing, and tightness in the chest. Treatment for emphysema focuses on managing symptoms and slowing down the progression of the disease. Medication is the therapeutic interventions for emphysema treatment.
Surge in prevalence of emphysema and rise in number of smokers are expected to drive the growth of the emphysema treatment market. For instance, according to 2024 article by American Lung Association, it was estimated that over 3 million people in the U.S. have been diagnosed with emphysema. Furthermore, according to a report by Foundation for a Smoke-Free World, it was reported that prevalence of smoking in India was estimated to be 4.6%.

Report Includes:

This definitive report equips CEOs, marketing directors, and investors with a 360° view of the global Emphysema Treatment Medication market across value chain. It analyzes historical revenue data (2020–2024) and delivers forecasts through 2031, illuminating demand trends and growth drivers.
By segmenting the market by Type and by Application, the study quantifies market size, growth rates, niche opportunities, and substitution risks, and analyzes downstream customers distribution pattern.
Granular regional insights cover five major markets—North America, Europe, APAC, South America, and MEA—with in‑depth analysis of 20+ countries, detailing dominant products, competitive landscape, and downstream demand trends.
Critical competitive intelligence profiles players—revenue, margins, pricing strategies, and major customers—and dissects the top-player positioning across product lines, applications, and regions to reveal strategic strengths.
A concise Industry‑chain overview maps upstream, middlestream, and downstream distribution dynamics to identify strategic gaps and unmet demand.
Market Segmentation

Scope of Emphysema Treatment Medication Market Report

Report Metric Details
Report Name Emphysema Treatment Medication Market
Accounted market size in 2024 US$ 4266 million
Forecasted market size in 2031 US$ 5331 million
CAGR 3.3%
Base Year 2024
Forecasted years 2025 - 2031
Segment by Type
  • Bronchodilators
  • Steroids
  • Others
Segment by Application
  • Hospitals
  • Homecare
  • Others
Sales by Region
  • North America (United States, Canada)
  • Europe (Germany, France, UK, Italy, Russia) Rest of Europe
  • Nordic Countries
  • Asia-Pacific (China, Japan, South Korea)
  • Southeast Asia (India, Australia)
  • Rest of Asia
  • Latin America (Mexico, Brazil)
  • Rest of Latin America
  • Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of MEA)
By Company Emphasys Medical, Pfizer, Uptake Medical, Inogen, Inc, Viatris Inc, Boehringer Ingelheim International GmbH, Novartis AG, AstraZeneca, Orion Corporation, Teva Pharmaceutical Industries Ltd, Verona Pharma Plc, GlaxoSmithKline Plc, Pulmonx, Bioxyne, Intrexon, Icure Pharmaceuticals, Kamada
Forecast units USD million in value
Report coverage Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Chapter Outline

  • Chapter 1: Defines the Emphysema Treatment Medication study scope, segments the market by Type and by Application, etc, highlights segment size and growth potential.
  • Chapter 2: Offers current market state, projects global revenue and sales to 2031, pinpointing high consumption regions and emerging market catalysts
  • Chapter 3: Dissects the player landscape—ranks by revenue and profitability, details Player performance by product type and evaluates concentration alongside M&A moves.
  • Chapter 4: Unlocks high margin product segments—compares revenue, ASP, and technology differentiators, highlighting growth niches and substitution risks
  • Chapter 5: Targets downstream market opportunities—evaluates market size by Application, identifies emerging use cases, and profiles leading customers by region and by Application.
  • Chapter 6: North America—breaks down market size by Type, by Application and country, profiles key players and assesses growth drivers and barriers.
  • Chapter 7: Europe—analyses regional market by Type, by Application and players, flagging drivers and barriers.
  • Chapter 8: Asia Pacific—quantifies market size by Type, by Application, and region/country, profiles top players, and uncovers high potential expansion areas.
  • Chapter 9: Central & South America—measures market size by Type, by Application, and country, profiles top players, and identifies investment opportunities and challenges.
  • Chapter 10: Middle East and Africa—evaluates market size by Type, by Application, and country, profiles key players, and outlines investment prospects and market hurdles
  • Chapter 11: Profiles players in depth—details product specs, revenue, margins; Top-tier players 2024 sales breakdowns by Product type, by Application, by region SWOT analysis, and recent strategic developments.
  • Chapter 12: Industry chain—analyses upstream, cost drivers, plus downstream channels.
  • Chapter 13: Market dynamics—explores drivers, restraints, regulatory impacts, and risk mitigation strategies.
  • Chapter 14: Actionable conclusions and strategic recommendations.
  • Why This Report:
  • Beyond standard market data, this analysis provides a clear profitability roadmap—empowering you to:
  • Allocate capital strategically to high growth regions (Chapters 6–10) and margin rich segments (Chapter 5).
  • Negotiate from strength with suppliers (Chapter 12) and customers (Chapter 5) using cost and demand intelligence.
  • Outmaneuver competitors with granular insights into their operations, margins, and strategies (Chapters 3 and 11).
  • Capitalize on the projected billion‑dollar opportunity with data‑driven regional and segment tactics (Chapter 12-14).
  • Leverage this 360° intelligence to turn market complexity into actionable competitive advantage.

FAQ for this report

How fast is Emphysema Treatment Medication Market growing?

Ans: The Emphysema Treatment Medication Market witnessing a CAGR of 3.3% during the forecast period 2025-2031.

What is the Emphysema Treatment Medication Market size in 2031?

Ans: The Emphysema Treatment Medication Market size in 2031 will be US$ 5331 million.

What is the Emphysema Treatment Medication Market share by region?

Ans: Furthermore, according to a report by Foundation for a Smoke-Free World, it was reported that prevalence of smoking in India was estimated to be 4.6%.

Who are the main players in the Emphysema Treatment Medication Market report?

Ans: The main players in the Emphysema Treatment Medication Market are Emphasys Medical, Pfizer, Uptake Medical, Inogen, Inc, Viatris Inc, Boehringer Ingelheim International GmbH, Novartis AG, AstraZeneca, Orion Corporation, Teva Pharmaceutical Industries Ltd, Verona Pharma Plc, GlaxoSmithKline Plc, Pulmonx, Bioxyne, Intrexon, Icure Pharmaceuticals, Kamada

What are the Application segmentation covered in the Emphysema Treatment Medication Market report?

Ans: The Applications covered in the Emphysema Treatment Medication Market report are Hospitals, Homecare, Others

What are the Type segmentation covered in the Emphysema Treatment Medication Market report?

Ans: The Types covered in the Emphysema Treatment Medication Market report are Bronchodilators, Steroids, Others

1 Study Coverage
1.1 Introduction to Emphysema Treatment Medication: Definition, Properties, and Key Attributes
1.2 Market Segmentation by Type
1.2.1 Global Emphysema Treatment Medication Market Size by Type, 2020 VS 2024 VS 2031
1.2.2 Bronchodilators
1.2.3 Steroids
1.2.4 Others
1.3 Market Segmentation by Application
1.3.1 Global Emphysema Treatment Medication Market Size by Application, 2020 VS 2024 VS 2031
1.3.2 Hospitals
1.3.3 Homecare
1.3.4 Others
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Executive Summary
2.1 Global Emphysema Treatment Medication Revenue Estimates and Forecasts 2020-2031
2.2 Global Emphysema Treatment Medication Revenue by Region
2.2.1 Revenue Comparison: 2020 VS 2024 VS 2031
2.2.2 Historical and Forecasted Revenue by Region (2020-2031)
2.2.3 Global Revenue Market Share by Region (2020-2031)
2.2.4 Emerging Market Focus: Growth Drivers & Investment Trends
3 Competition by Players
3.1 Global Emphysema Treatment Medication Player Revenue Rankings and Profitability
3.1.1 Global Revenue (Value) by Players (2020-2025)
3.1.2 Global Key Player Revenue Ranking (2023 vs. 2024)
3.1.3 Revenue-Based Tier Segmentation (Tier 1, Tier 2, and Tier 3)
3.1.4 Gross Margin by Top Player (2020 VS 2024)
3.2 Global Emphysema Treatment Medication Companies Headquarters and Service Footprint
3.3 Main Product Type Market Size by Players
3.3.1 Bronchodilators Market Size by Players
3.3.2 Steroids Market Size by Players
3.3.3 Others Market Size by Players
3.4 Global Emphysema Treatment Medication Market Concentration and Dynamics
3.4.1 Global Market Concentration (CR5 and HHI)
3.4.2 Entrant/Exit Impact Analysis
3.4.3 Strategic Moves: M&A, Expansion, R&D Investment
4 Global Product Segmentation Analysis
4.1 Global Emphysema Treatment Medication Revenue Trends by Type
4.1.1 Global Historical and Forecasted Revenue by Type (2020-2031)
4.1.2 Global Revenue Market Share by Type (2020-2031)
4.2 Key Product Attributes and Differentiation
4.3 Subtype Dynamics: Growth Leaders, Profitability and Risk
4.3.1 High-Growth Niches and Adoption Drivers
4.3.2 Profitability Hotspots and Cost Drivers
4.3.3 Substitution Threats
5 Global Downstream Application Analysis
5.1 Global Emphysema Treatment Medication Revenue by Application
5.1.1 Global Historical and Forecasted Revenue by Application (2020-2031)
5.1.2 Revenue Market Share by Application (2020-2031)
5.1.3 High-Growth Application Identification
5.1.4 Emerging Application Case Studies
5.2 Downstream Customer Analysis
5.2.1 Top Customers by Region
5.2.2 Top Customers by Application
6 North America
6.1 North America Market Size (2020-2031)
6.2 North America Key Players Revenue in 2024
6.3 North America Emphysema Treatment Medication Market Size by Type (2020-2031)
6.4 North America Emphysema Treatment Medication Market Size by Application (2020-2031)
6.5 North America Growth Accelerators and Market Barriers
6.6 North America Emphysema Treatment Medication Market Size by Country
6.6.1 North America Revenue Trends by Country
6.6.2 US
6.6.3 Canada
6.6.4 Mexico
7 Europe
7.1 Europe Market Size (2020-2031)
7.2 Europe Key Players Revenue in 2024
7.3 Europe Emphysema Treatment Medication Market Size by Type (2020-2031)
7.4 Europe Emphysema Treatment Medication Market Size by Application (2020-2031)
7.5 Europe Growth Accelerators and Market Barriers
7.6 Europe Emphysema Treatment Medication Market Size by Country
7.6.1 Europe Revenue Trends by Country
7.6.2 Germany
7.6.3 France
7.6.4 U.K.
7.6.5 Italy
7.6.6 Russia
8 Asia-Pacific
8.1 Asia-Pacific Market Size (2020-2031)
8.2 Asia-Pacific Key Players Revenue in 2024
8.3 Asia-Pacific Emphysema Treatment Medication Market Size by Type (2020-2031)
8.4 Asia-Pacific Emphysema Treatment Medication Market Size by Application (2020-2031)
8.5 Asia-Pacific Growth Accelerators and Market Barriers
8.6 Asia-Pacific Emphysema Treatment Medication Market Size by Region
8.6.1 Asia-Pacific Revenue Trends by Region
8.7 China
8.8 Japan
8.9 South Korea
8.10 Australia
8.11 India
8.12 Southeast Asia
8.12.1 Indonesia
8.12.2 Vietnam
8.12.3 Malaysia
8.12.4 Philippines
8.12.5 Singapore
9 Central and South America
9.1 Central and South America Market Size (2020-2031)
9.2 Central and South America Key Players Revenue in 2024
9.3 Central and South America Emphysema Treatment Medication Market Size by Type (2020-2031)
9.4 Central and South America Emphysema Treatment Medication Market Size by Application (2020-2031)
9.5 Central and South America Investment Opportunities and Key Challenges
9.6 Central and South America Emphysema Treatment Medication Market Size by Country
9.6.1 Central and South America Revenue Trends by Country (2020 VS 2024 VS 2031)
9.6.2 Brazil
9.6.3 Argentina
10 Middle East and Africa
10.1 Middle East and Africa Market Size (2020-2031)
10.2 Middle East and Africa Key Players Revenue in 2024
10.3 Middle East and Africa Emphysema Treatment Medication Market Size by Type (2020-2031)
10.4 Middle East and Africa Emphysema Treatment Medication Market Size by Application (2020-2031)
10.5 Middle East and Africa Investment Opportunities and Key Challenges
10.6 Middle East and Africa Emphysema Treatment Medication Market Size by Country
10.6.1 Middle East and Africa Revenue Trends by Country (2020 VS 2024 VS 2031)
10.6.2 GCC Countries
10.6.3 Israel
10.6.4 Egypt
10.6.5 South Africa
11 Corporate Profile
11.1 Emphasys Medical
11.1.1 Emphasys Medical Corporation Information
11.1.2 Emphasys Medical Business Overview
11.1.3 Emphasys Medical Emphysema Treatment Medication Product Features and Attributes
11.1.4 Emphasys Medical Emphysema Treatment Medication Revenue and Gross Margin (2020-2025)
11.1.5 Emphasys Medical Emphysema Treatment Medication Revenue by Product in 2024
11.1.6 Emphasys Medical Emphysema Treatment Medication Revenue by Application in 2024
11.1.7 Emphasys Medical Emphysema Treatment Medication Revenue by Geographic Area in 2024
11.1.8 Emphasys Medical Emphysema Treatment Medication SWOT Analysis
11.1.9 Emphasys Medical Recent Developments
11.2 Pfizer
11.2.1 Pfizer Corporation Information
11.2.2 Pfizer Business Overview
11.2.3 Pfizer Emphysema Treatment Medication Product Features and Attributes
11.2.4 Pfizer Emphysema Treatment Medication Revenue and Gross Margin (2020-2025)
11.2.5 Pfizer Emphysema Treatment Medication Revenue by Product in 2024
11.2.6 Pfizer Emphysema Treatment Medication Revenue by Application in 2024
11.2.7 Pfizer Emphysema Treatment Medication Revenue by Geographic Area in 2024
11.2.8 Pfizer Emphysema Treatment Medication SWOT Analysis
11.2.9 Pfizer Recent Developments
11.3 Uptake Medical
11.3.1 Uptake Medical Corporation Information
11.3.2 Uptake Medical Business Overview
11.3.3 Uptake Medical Emphysema Treatment Medication Product Features and Attributes
11.3.4 Uptake Medical Emphysema Treatment Medication Revenue and Gross Margin (2020-2025)
11.3.5 Uptake Medical Emphysema Treatment Medication Revenue by Product in 2024
11.3.6 Uptake Medical Emphysema Treatment Medication Revenue by Application in 2024
11.3.7 Uptake Medical Emphysema Treatment Medication Revenue by Geographic Area in 2024
11.3.8 Uptake Medical Emphysema Treatment Medication SWOT Analysis
11.3.9 Uptake Medical Recent Developments
11.4 Inogen, Inc
11.4.1 Inogen, Inc Corporation Information
11.4.2 Inogen, Inc Business Overview
11.4.3 Inogen, Inc Emphysema Treatment Medication Product Features and Attributes
11.4.4 Inogen, Inc Emphysema Treatment Medication Revenue and Gross Margin (2020-2025)
11.4.5 Inogen, Inc Emphysema Treatment Medication Revenue by Product in 2024
11.4.6 Inogen, Inc Emphysema Treatment Medication Revenue by Application in 2024
11.4.7 Inogen, Inc Emphysema Treatment Medication Revenue by Geographic Area in 2024
11.4.8 Inogen, Inc Emphysema Treatment Medication SWOT Analysis
11.4.9 Inogen, Inc Recent Developments
11.5 Viatris Inc
11.5.1 Viatris Inc Corporation Information
11.5.2 Viatris Inc Business Overview
11.5.3 Viatris Inc Emphysema Treatment Medication Product Features and Attributes
11.5.4 Viatris Inc Emphysema Treatment Medication Revenue and Gross Margin (2020-2025)
11.5.5 Viatris Inc Emphysema Treatment Medication Revenue by Product in 2024
11.5.6 Viatris Inc Emphysema Treatment Medication Revenue by Application in 2024
11.5.7 Viatris Inc Emphysema Treatment Medication Revenue by Geographic Area in 2024
11.5.8 Viatris Inc Emphysema Treatment Medication SWOT Analysis
11.5.9 Viatris Inc Recent Developments
11.6 Boehringer Ingelheim International GmbH
11.6.1 Boehringer Ingelheim International GmbH Corporation Information
11.6.2 Boehringer Ingelheim International GmbH Business Overview
11.6.3 Boehringer Ingelheim International GmbH Emphysema Treatment Medication Product Features and Attributes
11.6.4 Boehringer Ingelheim International GmbH Emphysema Treatment Medication Revenue and Gross Margin (2020-2025)
11.6.5 Boehringer Ingelheim International GmbH Recent Developments
11.7 Novartis AG
11.7.1 Novartis AG Corporation Information
11.7.2 Novartis AG Business Overview
11.7.3 Novartis AG Emphysema Treatment Medication Product Features and Attributes
11.7.4 Novartis AG Emphysema Treatment Medication Revenue and Gross Margin (2020-2025)
11.7.5 Novartis AG Recent Developments
11.8 AstraZeneca
11.8.1 AstraZeneca Corporation Information
11.8.2 AstraZeneca Business Overview
11.8.3 AstraZeneca Emphysema Treatment Medication Product Features and Attributes
11.8.4 AstraZeneca Emphysema Treatment Medication Revenue and Gross Margin (2020-2025)
11.8.5 AstraZeneca Recent Developments
11.9 Orion Corporation
11.9.1 Orion Corporation Corporation Information
11.9.2 Orion Corporation Business Overview
11.9.3 Orion Corporation Emphysema Treatment Medication Product Features and Attributes
11.9.4 Orion Corporation Emphysema Treatment Medication Revenue and Gross Margin (2020-2025)
11.9.5 Orion Corporation Recent Developments
11.10 Teva Pharmaceutical Industries Ltd
11.10.1 Teva Pharmaceutical Industries Ltd Corporation Information
11.10.2 Teva Pharmaceutical Industries Ltd Business Overview
11.10.3 Teva Pharmaceutical Industries Ltd Emphysema Treatment Medication Product Features and Attributes
11.10.4 Teva Pharmaceutical Industries Ltd Emphysema Treatment Medication Revenue and Gross Margin (2020-2025)
11.10.5 Company Ten Recent Developments
11.11 Verona Pharma Plc
11.11.1 Verona Pharma Plc Corporation Information
11.11.2 Verona Pharma Plc Business Overview
11.11.3 Verona Pharma Plc Emphysema Treatment Medication Product Features and Attributes
11.11.4 Verona Pharma Plc Emphysema Treatment Medication Revenue and Gross Margin (2020-2025)
11.11.5 Verona Pharma Plc Recent Developments
11.12 GlaxoSmithKline Plc
11.12.1 GlaxoSmithKline Plc Corporation Information
11.12.2 GlaxoSmithKline Plc Business Overview
11.12.3 GlaxoSmithKline Plc Emphysema Treatment Medication Product Features and Attributes
11.12.4 GlaxoSmithKline Plc Emphysema Treatment Medication Revenue and Gross Margin (2020-2025)
11.12.5 GlaxoSmithKline Plc Recent Developments
11.13 Pulmonx
11.13.1 Pulmonx Corporation Information
11.13.2 Pulmonx Business Overview
11.13.3 Pulmonx Emphysema Treatment Medication Product Features and Attributes
11.13.4 Pulmonx Emphysema Treatment Medication Revenue and Gross Margin (2020-2025)
11.13.5 Pulmonx Recent Developments
11.14 Bioxyne
11.14.1 Bioxyne Corporation Information
11.14.2 Bioxyne Business Overview
11.14.3 Bioxyne Emphysema Treatment Medication Product Features and Attributes
11.14.4 Bioxyne Emphysema Treatment Medication Revenue and Gross Margin (2020-2025)
11.14.5 Bioxyne Recent Developments
11.15 Intrexon
11.15.1 Intrexon Corporation Information
11.15.2 Intrexon Business Overview
11.15.3 Intrexon Emphysema Treatment Medication Product Features and Attributes
11.15.4 Intrexon Emphysema Treatment Medication Revenue and Gross Margin (2020-2025)
11.15.5 Intrexon Recent Developments
11.16 Icure Pharmaceuticals
11.16.1 Icure Pharmaceuticals Corporation Information
11.16.2 Icure Pharmaceuticals Business Overview
11.16.3 Icure Pharmaceuticals Emphysema Treatment Medication Product Features and Attributes
11.16.4 Icure Pharmaceuticals Emphysema Treatment Medication Revenue and Gross Margin (2020-2025)
11.16.5 Icure Pharmaceuticals Recent Developments
11.17 Kamada
11.17.1 Kamada Corporation Information
11.17.2 Kamada Business Overview
11.17.3 Kamada Emphysema Treatment Medication Product Features and Attributes
11.17.4 Kamada Emphysema Treatment Medication Revenue and Gross Margin (2020-2025)
11.17.5 Kamada Recent Developments
12 Emphysema Treatment MedicationIndustry Chain Analysis
12.1 Emphysema Treatment Medication Industry Chain
12.2 Upstream Analysis
12.2.1 Upstream Key Suppliers
12.3 Middlestream Analysis
12.4 Downstream Sales Model and Distribution Networks
12.4.1 Sales Channels
12.4.2 Distributors
13 Emphysema Treatment Medication Market Dynamics
13.1 Industry Trends and Evolution
13.2 Market Growth Drivers and Emerging Opportunities
13.3 Market Challenges, Risks, and Restraints
14 Key Findings in the Global Emphysema Treatment Medication Study
15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.1.1 Research Programs/Design
15.1.1.2 Market Size Estimation
15.1.1.3 Market Breakdown and Data Triangulation
15.1.2 Data Source
15.1.2.1 Secondary Sources
15.1.2.2 Primary Sources
15.2 Author Details
FEATURED COMPANIES
Emphasys Medical
Pfizer Inc
Uptake Medical
Inogen
Viatris
Boehringer Ingelheim International GmbH
Novartis
Astrazeneca plc
Orion Corporation
Teva Pharmaceutical Industries Ltd
Verona Pharma Plc
GlaxoSmithKline PLC
Pulmonx
Bioxyne
Intrexon
Icure Pharmaceuticals
Kamada
List of Tables
 Table 1. Global Emphysema Treatment Medication Market Size Growth Rate by Type, 2020 VS 2024 VS 2031 (US$ Million)
 Table 2. Global Emphysema Treatment Medication Market Size Growth Rate by Application, 2020 VS 2024 VS 2031 (US$ Million)
 Table 3. Global Emphysema Treatment Medication Revenue Grow Rate (CAGR) by Region: 2020 VS 2024 VS 2031 (US$ Million)
 Table 4. Global Emphysema Treatment Medication Revenue by Region (2020-2025) & (US$ Million)
 Table 5. Global Emphysema Treatment Medication Revenue by Region (2026-2031) & (US$ Million)
 Table 6. Emerging Market Revenue Grow Rate (CAGR) by Country (2020 VS 2024 VS 2031) (US$ Million)
 Table 7. Global Emphysema Treatment Medication Revenue by Players (2020-2025) & (US$ Million)
 Table 8. Global Emphysema Treatment Medication Revenue Market Share by Players (2020-2025)
 Table 9. Global Key Players’Ranking Shift (2023 vs. 2024) (Based on Revenue)
 Table 10. Global Emphysema Treatment Medication by Player Tier (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Emphysema Treatment Medication as of 2024)
 Table 11. Global Emphysema Treatment Medication Average Gross Margin (%) by Player (2020 VS 2024)
 Table 12. Global Emphysema Treatment Medication Companies Headquarters
 Table 13. Global Emphysema Treatment Medication Market Concentration Ratio (CR5 and HHI)
 Table 14. Key Market Entrant/Exit (2020-2024) – Drivers & Impact Analysis
 Table 15. Key Mergers & Acquisitions, Expansion Plans, R&D Investment
 Table 16. Global Emphysema Treatment Medication Revenue by Type (2020-2025) & (US$ Million)
 Table 17. Global Emphysema Treatment Medication Revenue by Type (2026-2031) & (US$ Million)
 Table 18. Key Product Attributes and Differentiation
 Table 19. Global Emphysema Treatment Medication Revenue by Application (2020-2025) & (US$ Million)
 Table 20. Global Emphysema Treatment Medication Revenue by Application (2026-2031) & (US$ Million)
 Table 21. Emphysema Treatment Medication High-Growth Sectors Demand CAGR (2024-2031)
 Table 22. Top Customers by Region
 Table 23. Top Customers by Application
 Table 24. North America Emphysema Treatment Medication Growth Accelerators and Market Barriers
 Table 25. North America Emphysema Treatment Medication Revenue Grow Rate (CAGR) by Country (2020 VS 2024 VS 2031) (US$ Million)
 Table 26. Europe Emphysema Treatment Medication Growth Accelerators and Market Barriers
 Table 27. Europe Emphysema Treatment Medication Revenue Grow Rate (CAGR) by Country: 2020 VS 2024 VS 2031 (US$ Million)
 Table 28. Asia-Pacific Emphysema Treatment Medication Growth Accelerators and Market Barriers
 Table 29. Asia-Pacific Emphysema Treatment Medication Revenue Grow Rate (CAGR) by Region: 2020 VS 2024 VS 2031 (US$ Million)
 Table 30. Central and South America Emphysema Treatment Medication Investment Opportunities and Key Challenges
 Table 31. Central and South America Emphysema Treatment Medication Revenue Grow Rate (CAGR) by Country (2020 VS 2024 VS 2031) (US$ Million)
 Table 32. Middle East and Africa Emphysema Treatment Medication Investment Opportunities and Key Challenges
 Table 33. Middle East and Africa Emphysema Treatment Medication Revenue Grow Rate (CAGR) by Country (2020 VS 2024 VS 2031) (US$ Million)
 Table 34. Emphasys Medical Corporation Information
 Table 35. Emphasys Medical Description and Major Businesses
 Table 36. Emphasys Medical Product Features and Attributes
 Table 37. Emphasys Medical Revenue (US$ Million) and Gross Margin (2020-2025)
 Table 38. Emphasys Medical Revenue Proportion by Product in 2024
 Table 39. Emphasys Medical Revenue Proportion by Application in 2024
 Table 40. Emphasys Medical Revenue Proportion by Geographic Area in 2024
 Table 41. Emphasys Medical Emphysema Treatment Medication SWOT Analysis
 Table 42. Emphasys Medical Recent Developments
 Table 43. Pfizer Corporation Information
 Table 44. Pfizer Description and Major Businesses
 Table 45. Pfizer Product Features and Attributes
 Table 46. Pfizer Revenue (US$ Million) and Gross Margin (2020-2025)
 Table 47. Pfizer Revenue Proportion by Product in 2024
 Table 48. Pfizer Revenue Proportion by Application in 2024
 Table 49. Pfizer Revenue Proportion by Geographic Area in 2024
 Table 50. Pfizer Emphysema Treatment Medication SWOT Analysis
 Table 51. Pfizer Recent Developments
 Table 52. Uptake Medical Corporation Information
 Table 53. Uptake Medical Description and Major Businesses
 Table 54. Uptake Medical Product Features and Attributes
 Table 55. Uptake Medical Revenue (US$ Million) and Gross Margin (2020-2025)
 Table 56. Uptake Medical Revenue Proportion by Product in 2024
 Table 57. Uptake Medical Revenue Proportion by Application in 2024
 Table 58. Uptake Medical Revenue Proportion by Geographic Area in 2024
 Table 59. Uptake Medical Emphysema Treatment Medication SWOT Analysis
 Table 60. Uptake Medical Recent Developments
 Table 61. Inogen, Inc Corporation Information
 Table 62. Inogen, Inc Description and Major Businesses
 Table 63. Inogen, Inc Product Features and Attributes
 Table 64. Inogen, Inc Revenue (US$ Million) and Gross Margin (2020-2025)
 Table 65. Inogen, Inc Revenue Proportion by Product in 2024
 Table 66. Inogen, Inc Revenue Proportion by Application in 2024
 Table 67. Inogen, Inc Revenue Proportion by Geographic Area in 2024
 Table 68. Inogen, Inc Emphysema Treatment Medication SWOT Analysis
 Table 69. Inogen, Inc Recent Developments
 Table 70. Viatris Inc Corporation Information
 Table 71. Viatris Inc Description and Major Businesses
 Table 72. Viatris Inc Product Features and Attributes
 Table 73. Viatris Inc Revenue (US$ Million) and Gross Margin (2020-2025)
 Table 74. Viatris Inc Revenue Proportion by Product in 2024
 Table 75. Viatris Inc Revenue Proportion by Application in 2024
 Table 76. Viatris Inc Revenue Proportion by Geographic Area in 2024
 Table 77. Viatris Inc Emphysema Treatment Medication SWOT Analysis
 Table 78. Viatris Inc Recent Developments
 Table 79. Boehringer Ingelheim International GmbH Corporation Information
 Table 80. Boehringer Ingelheim International GmbH Description and Major Businesses
 Table 81. Boehringer Ingelheim International GmbH Product Features and Attributes
 Table 82. Boehringer Ingelheim International GmbH Revenue (US$ Million) and Gross Margin (2020-2025)
 Table 83. Boehringer Ingelheim International GmbH Recent Developments
 Table 84. Novartis AG Corporation Information
 Table 85. Novartis AG Description and Major Businesses
 Table 86. Novartis AG Product Features and Attributes
 Table 87. Novartis AG Revenue (US$ Million) and Gross Margin (2020-2025)
 Table 88. Novartis AG Recent Developments
 Table 89. AstraZeneca Corporation Information
 Table 90. AstraZeneca Description and Major Businesses
 Table 91. AstraZeneca Product Features and Attributes
 Table 92. AstraZeneca Revenue (US$ Million) and Gross Margin (2020-2025)
 Table 93. AstraZeneca Recent Developments
 Table 94. Orion Corporation Corporation Information
 Table 95. Orion Corporation Description and Major Businesses
 Table 96. Orion Corporation Product Features and Attributes
 Table 97. Orion Corporation Revenue (US$ Million) and Gross Margin (2020-2025)
 Table 98. Orion Corporation Recent Developments
 Table 99. Teva Pharmaceutical Industries Ltd Corporation Information
 Table 100. Teva Pharmaceutical Industries Ltd Description and Major Businesses
 Table 101. Teva Pharmaceutical Industries Ltd Product Features and Attributes
 Table 102. Teva Pharmaceutical Industries Ltd Revenue (US$ Million) and Gross Margin (2020-2025)
 Table 103. Teva Pharmaceutical Industries Ltd Recent Developments
 Table 104. Verona Pharma Plc Corporation Information
 Table 105. Verona Pharma Plc Description and Major Businesses
 Table 106. Verona Pharma Plc Product Features and Attributes
 Table 107. Verona Pharma Plc Revenue (US$ Million) and Gross Margin (2020-2025)
 Table 108. Verona Pharma Plc Recent Developments
 Table 109. GlaxoSmithKline Plc Corporation Information
 Table 110. GlaxoSmithKline Plc Description and Major Businesses
 Table 111. GlaxoSmithKline Plc Product Features and Attributes
 Table 112. GlaxoSmithKline Plc Revenue (US$ Million) and Gross Margin (2020-2025)
 Table 113. GlaxoSmithKline Plc Recent Developments
 Table 114. Pulmonx Corporation Information
 Table 115. Pulmonx Description and Major Businesses
 Table 116. Pulmonx Product Features and Attributes
 Table 117. Pulmonx Revenue (US$ Million) and Gross Margin (2020-2025)
 Table 118. Pulmonx Recent Developments
 Table 119. Bioxyne Corporation Information
 Table 120. Bioxyne Description and Major Businesses
 Table 121. Bioxyne Product Features and Attributes
 Table 122. Bioxyne Revenue (US$ Million) and Gross Margin (2020-2025)
 Table 123. Bioxyne Recent Developments
 Table 124. Intrexon Corporation Information
 Table 125. Intrexon Description and Major Businesses
 Table 126. Intrexon Product Features and Attributes
 Table 127. Intrexon Revenue (US$ Million) and Gross Margin (2020-2025)
 Table 128. Intrexon Recent Developments
 Table 129. Icure Pharmaceuticals Corporation Information
 Table 130. Icure Pharmaceuticals Description and Major Businesses
 Table 131. Icure Pharmaceuticals Product Features and Attributes
 Table 132. Icure Pharmaceuticals Revenue (US$ Million) and Gross Margin (2020-2025)
 Table 133. Icure Pharmaceuticals Recent Developments
 Table 134. Kamada Corporation Information
 Table 135. Kamada Description and Major Businesses
 Table 136. Kamada Product Features and Attributes
 Table 137. Kamada Revenue (US$ Million) and Gross Margin (2020-2025)
 Table 138. Kamada Recent Developments
 Table 139. Raw Materials Key Suppliers
 Table 140. Distributors List
 Table 141. Market Trends and Market Evolution
 Table 142. Market Drivers and Opportunities
 Table 143. Market Challenges, Risks, and Restraints
 Table 144. Research Programs/Design for This Report
 Table 145. Key Data Information from Secondary Sources
 Table 146. Key Data Information from Primary Sources


List of Figures
 Figure 1. Emphysema Treatment Medication Product Picture
 Figure 2. Global Emphysema Treatment Medication Market Size Growth Rate by Type, 2020 VS 2024 VS 2031 (US$ Million)
 Figure 3. Bronchodilators Product Picture
 Figure 4. Steroids Product Picture
 Figure 5. Others Product Picture
 Figure 6. Global Emphysema Treatment Medication Market Size Growth Rate by Application, 2020 VS 2024 VS 2031 (US$ Million)
 Figure 7. Hospitals
 Figure 8. Homecare
 Figure 9. Others
 Figure 10. Emphysema Treatment Medication Report Years Considered
 Figure 11. Global Emphysema Treatment Medication Revenue, (US$ Million), 2020 VS 2024 VS 2031
 Figure 12. Global Emphysema Treatment Medication Revenue (2020-2031) & (US$ Million)
 Figure 13. Global Emphysema Treatment Medication Revenue (CAGR) by Region: 2020 VS 2024 VS 2031 (US$ Million)
 Figure 14. Global Emphysema Treatment Medication Revenue Market Share by Region (2020-2031)
 Figure 15. Global Emphysema Treatment Medication Revenue Market Share Ranking (2024)
 Figure 16. Tier Distribution by Revenue Contribution (2020 VS 2024)
 Figure 17. Bronchodilators Revenue Market Share by Player in 2024
 Figure 18. Steroids Revenue Market Share by Player in 2024
 Figure 19. Others Revenue Market Share by Player in 2024
 Figure 20. Global Emphysema Treatment Medication Revenue Market Share by Type (2020-2031)
 Figure 21. Global Emphysema Treatment Medication Revenue Market Share by Application (2020-2031)
 Figure 22. North America Emphysema Treatment Medication Revenue YoY (2020-2031) & (US$ Million)
 Figure 23. North America Top 5 Players Emphysema Treatment Medication Revenue (US$ Million) in 2024
 Figure 24. North America Emphysema Treatment Medication Revenue (US$ Million) by Type (2020 - 2031)
 Figure 25. North America Emphysema Treatment Medication Revenue (US$ Million) by Application (2020-2031)
 Figure 26. US Emphysema Treatment Medication Revenue (2020-2031) & (US$ Million)
 Figure 27. Canada Emphysema Treatment Medication Revenue (2020-2031) & (US$ Million)
 Figure 28. Mexico Emphysema Treatment Medication Revenue (2020-2031) & (US$ Million)
 Figure 29. Europe Emphysema Treatment Medication Revenue YoY (2020-2031) & (US$ Million)
 Figure 30. Europe Top 5 Players Emphysema Treatment Medication Revenue (US$ Million) in 2024
 Figure 31. Europe Emphysema Treatment Medication Revenue (US$ Million) by Type (2020-2031)
 Figure 32. Europe Emphysema Treatment Medication Revenue (US$ Million) by Application (2020-2031)
 Figure 33. Germany Emphysema Treatment Medication Revenue (2020-2031) & (US$ Million)
 Figure 34. France Emphysema Treatment Medication Revenue (2020-2031) & (US$ Million)
 Figure 35. U.K. Emphysema Treatment Medication Revenue (2020-2031) & (US$ Million)
 Figure 36. Italy Emphysema Treatment Medication Revenue (2020-2031) & (US$ Million)
 Figure 37. Russia Emphysema Treatment Medication Revenue (2020-2031) & (US$ Million)
 Figure 38. Asia-Pacific Emphysema Treatment Medication Revenue YoY (2020-2031) & (US$ Million)
 Figure 39. Asia-Pacific Top 8 Players Emphysema Treatment Medication Revenue (US$ Million) in 2024
 Figure 40. Asia-Pacific Emphysema Treatment Medication Revenue (US$ Million) by Type (2020-2031)
 Figure 41. Asia-Pacific Emphysema Treatment Medication Revenue (US$ Million) by Application (2020-2031)
 Figure 42. Indonesia Emphysema Treatment Medication Revenue (2020-2031) & (US$ Million)
 Figure 43. Japan Emphysema Treatment Medication Revenue (2020-2031) & (US$ Million)
 Figure 44. South Korea Emphysema Treatment Medication Revenue (2020-2031) & (US$ Million)
 Figure 45. Australia Emphysema Treatment Medication Revenue (2020-2031) & (US$ Million)
 Figure 46. India Emphysema Treatment Medication Revenue (2020-2031) & (US$ Million)
 Figure 47. Indonesia Emphysema Treatment Medication Revenue (2020-2031) & (US$ Million)
 Figure 48. Vietnam Emphysema Treatment Medication Revenue (2020-2031) & (US$ Million)
 Figure 49. Malaysia Emphysema Treatment Medication Revenue (2020-2031) & (US$ Million)
 Figure 50. Philippines Emphysema Treatment Medication Revenue (2020-2031) & (US$ Million)
 Figure 51. Singapore Emphysema Treatment Medication Revenue (2020-2031) & (US$ Million)
 Figure 52. Central and South America Emphysema Treatment Medication Revenue YoY (2020-2031) & (US$ Million)
 Figure 53. Central and South America Top 5 Players Emphysema Treatment Medication Revenue (US$ Million) in 2024
 Figure 54. Central and South America Emphysema Treatment Medication Revenue (US$ Million) by Type (2020-2031)
 Figure 55. Central and South America Emphysema Treatment Medication Revenue (US$ Million) by Application (2020-2031)
 Figure 56. Brazil Emphysema Treatment Medication Revenue (2020-2025) & (US$ Million)
 Figure 57. Argentina Emphysema Treatment Medication Revenue (2020-2025) & (US$ Million)
 Figure 58. Middle East and Africa Emphysema Treatment Medication Revenue YoY (2020-2031) & (US$ Million)
 Figure 59. Middle East and Africa Top 5 Players Emphysema Treatment Medication Revenue (US$ Million) in 2024
 Figure 60. South America Emphysema Treatment Medication Revenue (US$ Million) by Type (2020-2031)
 Figure 61. Middle East and Africa Emphysema Treatment Medication Revenue (US$ Million) by Application (2020-2031)
 Figure 62. GCC Countries Emphysema Treatment Medication Revenue (2020-2025) & (US$ Million)
 Figure 63. Israel Emphysema Treatment Medication Revenue (2020-2025) & (US$ Million)
 Figure 64. Egypt Emphysema Treatment Medication Revenue (2020-2025) & (US$ Million)
 Figure 65. South Africa Emphysema Treatment Medication Revenue (2020-2025) & (US$ Million)
 Figure 66. Emphysema Treatment Medication Industry Chain Mapping
 Figure 67. Channels of Distribution (Direct Vs Distribution)
 Figure 68. Bottom-up and Top-down Approaches for This Report
 Figure 69. Data Triangulation
 Figure 70. Key Executives Interviewed
SELECT A FORMAT
Added to Cart
Electronic (PDF)

$4900

This license allows only one user to access the PDF.
Electronic (PDF)

$7350

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together
Electronic (PDF)

$9800

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report
Add to Cart
Buy Now (15% Discount)
INQUIRE FOR DISCOUNT

HAVE A QUERY?

INQUIRE ABOUT REPORT EMAIL US

OUR CUSTOMER

Nano Dimension

SIMILAR REPORTS

Global Chronic Obstructive Pulmonary Disorder Market Research Report 2024
Emphysema Treatment Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
COPD Therapeutics Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Chronic Obstructive Pulmonary Disease Drugs Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Pulmonary Fibrosis Drug Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
COPD Medication Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Global Nebulizers Inhalers and Respirators for Asthma Treatment Market Research Report 2024
Dyspnea Treatment Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Anti Asthma Drugs Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Global Pneumoconiosis Treatment Market Insights Forecast to 2030
Global Asthma and COPD Devices Market Insights Forecast to 2030
Global COPD Inhaler Market Research Report 2025
Asthma Devices Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Chronic Obstructive Pulmonary Diseases Drugs Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Global Emphysema Drug Market Research Report 2025
Drug Inhaler Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Global Drug Treatment for Respiratory Disease Market Research Report 2024
Global Medical Nebulizer Market Research Report 2025
Global COPD Drugs Market Research Report 2024
Global Pneumothorax Treatment Devices Market Research Report 2025
Call
Buy Now
REQUEST FREE SAMPLE REPORT
Support Contacts
U.S. (TOLL FREE)
+1 (425) 388-2538
THE COMPANY
OUR PRODUCTS
CUSTOMER SUPPORT
POLICES
THE COMPANY
CUSTOMER SUPPORT
OUR PRODUCTS
POLICES
Copyright © 2018 Valuates.com. All Rights Reserved.
Sitemap - Privacy Policy - Terms & Conditions